The 20 Best Graft Versus Host Disease (GvHD) Doctors Near Me

Georg Schett practices practicing medicine in Erlangen, Germany. Mr. Schett is rated as an Elite expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Arthritis, Psoriatic Arthritis, Rheumatoid Arthritis (RA), Oophorectomy, and Lithotripsy.

Paul Emery practices practicing medicine in Leeds, United Kingdom. Mr. Emery is rated as an Elite expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Synovitis, and Palindromic Rheumatism.

Oliver Distler practices practicing medicine in Zurich, Switzerland. Mr. Distler is rated as an Elite expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Systemic Sclerosis (SSc), Scleroderma, Acute Interstitial Pneumonia, Lung Transplant, and Bone Marrow Transplant.

Amelia Langston is a Hematologist Oncology provider practicing medicine in Atlanta, Georgia. Dr. Langston is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 47 other conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Aplastic Anemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Langston is board certified in American Board Of Internal Medicine, 1989. Dr. Langston is currently accepting new patients.

Jacalyn Rosenblatt is a primary care provider, practicing in Internal Medicine in Boston, Massachusetts. Dr. Rosenblatt is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Smoldering Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Rosenblatt is board certified in American Board Of Internal Medicine and Royal College Of Physicians And Surgeons Of Canada. Dr. Rosenblatt is currently accepting new patients.

Dr. Pulsipher is currently the Division Chief of the Pediatric Hematology at Intermountain Primary Children's Hospital and Oncology, Director of the Children's and Adolescent Cancer Initiative at Huntsman Cancer Institute and a Presidential Chair in Pediatric Oncology and Hematology at the University of Utah.  Dr. Pulsipher is an internationally recognized expert in Bone Marrow Transplantation and Cellular Therapy, having directed the world's largest pediatric transplant research group for more than a decade (Pediatric Transplantation and Cellular Therapy Consortium).  He has run more than 20 multicenter trials in the field and is considered and expert in broad areas of transplantation and cellular therapy.  Areas of focus have included development of reduced toxicity approaches to transplantation of both malignant and non-malignant disorders with a focus on minimizing short and long-term effects of transplant.  For non-malignant disorders he has run national protocols that have improved safety for patients with immunodeficiencies, HLH, and bone marrow failure. For cancer, he has developed techniques allowing identification of patients who can avoid radiation-based treatments for leukemia.  This has included a novel approach to safer transplantation of patients using half-matched family donors (haploidentical donors) using a novel form of bone marrow graft engineering called alpha-beta T-cell depletion.  His desire to develop safer approaches has become a major focus as he has led major studies in the field of chimeric antigen receptor T-cells (CAR T-cells), a safer approach to cancer cure.  Dr. Pulsipher's work in cell therapy helped lead to the FDA approval of the first CART cell treatment, tisagenlecleucel, and he continues to run trials in CAR T, NK, and Viral Specific T-cell therapies. He has open protocols aimed at improving outcomes and his lab efforts are focused on making CAR T-cells that last longer and avoid overcome resistance by cancer cells. Dr. Pulsipher's interests have included ensuring that the families of those undergoing transplantation and cell therapy are psychologically well throughout the process.  To help with this, he has run several large trials assessing the safety and Quality of Life of pediatric bone marrow donors and is he currently running a large national trial looking at the psychological well-being of donor and recipient families as they go through the transplant process.For questions regarding Dr. Pulsipher's adult practice at the Huntsman Cancer Institute, or for questions about any of our clinical programs and for assistance identifying the right Hematology specialist for you or your family member, please contact our Clinical Care Specialist/New Patient Coordinator at (801) 587-4652. For questions regarding Dr. Pulsipher's pediatric practice and the Blood and Marrow Transplant Program at Primary Children's Medical Center, please call (801) 662-4830. Dr. Pulsipher is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Graft Versus Host Disease (GvHD), Leukemia, Aplastic Anemia, and Bone Marrow Transplant. Dr. Pulsipher is board certified in American Board Of Pediatrics. Dr. Pulsipher is currently accepting new patients.

Bruce Blazar is a Pediatrics specialist and a Pediatric Hematologist Oncology provider practicing medicine in Minneapolis, Minnesota. Dr. Blazar is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Leukemia, Congenital Aplastic Anemia, and Bone Marrow Transplant. Dr. Blazar is board certified in Pediatrics: American Board Of Pediatrics, 1983 and Pediatric Hematology-Oncology: American Board Of Pediatrics, 1984. Dr. Blazar is currently accepting new patients.

Muna Qayed is a Hematologist and an Oncologist practicing medicine in Atlanta, Georgia. Dr. Qayed is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Acute Lymphoblastic Leukemia (ALL), Leukemia, Thrombocytopenia, and Bone Marrow Transplant. Dr. Qayed is currently accepting new patients.

Christine Falk practices practicing medicine in Hannover, Germany. Ms. Falk is rated as a Distinguished expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS), Cytomegalovirus Infection, Hepatitis, Lung Transplant, and Kidney Transplant.

Bodo Grimbacher practices practicing medicine in Hannover, Germany. Grimbacher is rated as a Distinguished expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). They are also highly rated in 9 other conditions, according to our data. Their clinical expertise encompasses Common Variable Immune Deficiency, Hyper IgE Syndrome, Autosomal Dominant Hyper IgE Syndrome, Primary Immunodeficiency (PID), and Bone Marrow Transplant.

Elisabetta Miserocchi practices practicing medicine in Milan, Italy. Ms. Miserocchi is rated as a Distinguished expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Uveitis, Punctate Inner Choroidopathy, Juvenile Idiopathic Arthritis (JIA), Vitrectomy, and Gamma Knife Radiosurgery.

Klaus Warnatz practices practicing medicine in Freiburg, Germany. Mr. Warnatz is rated as a Distinguished expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Common Variable Immune Deficiency, Primary Immunodeficiency (PID), Activated PI3K Delta Syndrome (APDS), Severe Combined Immunodeficiency (SCID), and Bone Marrow Transplant.

Michael Grimley is a Hematologist and an Oncologist practicing medicine in Cincinnati, Ohio. Dr. Grimley is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Hemophagocytic Lymphohistiocytosis, Graft Versus Host Disease (GvHD), Reticulohistiocytoma, Histiocytosis, and Bone Marrow Transplant. Dr. Grimley is currently accepting new patients.

Julien Zuber practices practicing medicine in Paris, France. Mr. Zuber is rated as a Distinguished expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Atypical Hemolytic Uremic Syndrome (aHUS), D-Minus Hemolytic Uremic Syndrome, Hemolytic-Uremic Syndrome, Kidney Transplant, and Bone Marrow Transplant.

Pooja Khandelwal is a Hematologist and an Oncologist practicing medicine in Cincinnati, Ohio. Dr. Khandelwal is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Hemophagocytic Lymphohistiocytosis, Bone Marrow Transplant, and Bone Graft. Dr. Khandelwal is currently accepting new patients.

Alexey Maschan practices practicing medicine in Moscow, Russian Federation. Maschan is rated as a Distinguished expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). They are also highly rated in 26 other conditions, according to our data. Their clinical expertise encompasses Aplastic Anemia, Thrombocytopenia, Purpura, Wiskott-Aldrich Syndrome, and Bone Marrow Transplant.

Michael Maschan practices practicing medicine in Moscow, Russian Federation. Mr. Maschan is rated as a Distinguished expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Leukemia, Aplastic Anemia, Primary Immunodeficiency (PID), Graft Versus Host Disease (GvHD), and Bone Marrow Transplant.

Christine Duncan is a Hematologist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Duncan is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Hepatic Venoocclusive Disease with Immunodeficiency, Graft Versus Host Disease (GvHD), Hemophagocytic Lymphohistiocytosis, Bone Marrow Transplant, and Tissue Biopsy. Dr. Duncan is currently accepting new patients.

Dmitry Balashov practices practicing medicine in Moscow, Russian Federation. Mr. Balashov is rated as a Distinguished expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Nijmegen Breakage Syndrome, Primary Immunodeficiency (PID), Hemophagocytic Lymphohistiocytosis, Bone Marrow Transplant, and Splenectomy.

Hemalatha Rangarajan is a Hematologist and an Oncologist practicing medicine in Columbus, Ohio. Dr. Rangarajan is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemolytic Anemia, Congenital Hemolytic Anemia, Bone Marrow Transplant, and Bone Graft. Dr. Rangarajan is currently accepting new patients.